X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
oncology (47) 47
female (24) 24
aged (23) 23
middle aged (23) 23
antineoplastic agents - therapeutic use (22) 22
chemotherapy (22) 22
adult (20) 20
male (19) 19
pharmacology & pharmacy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
head and neck cancer (17) 17
head and neck neoplasms - drug therapy (17) 17
cancer (15) 15
antineoplastic agents - pharmacology (12) 12
carcinoma, squamous cell - drug therapy (12) 12
cisplatin (12) 12
index medicus (12) 12
phase-ii trial (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
neoplasms - drug therapy (9) 9
cetuximab (8) 8
clinical trials as topic (8) 8
methotrexate (8) 8
receptor, epidermal growth factor - antagonists & inhibitors (8) 8
signal transduction - drug effects (8) 8
solid tumors (8) 8
squamous-cell carcinoma (8) 8
animals (7) 7
cisplatin - administration & dosage (7) 7
epidermal growth factor receptor (7) 7
head and neck neoplasms - pathology (7) 7
induction chemotherapy (7) 7
neoplasm metastasis (7) 7
radiotherapy (7) 7
therapy (7) 7
treatment outcome (7) 7
tumors (7) 7
tyrosine kinase inhibitor (7) 7
drug therapy (6) 6
fluorouracil - administration & dosage (6) 6
growth-factor receptor (6) 6
metastasis (6) 6
quinazolines - administration & dosage (6) 6
trial (6) 6
5-fluorouracil (5) 5
antineoplastic agents - administration & dosage (5) 5
drug administration schedule (5) 5
enzyme inhibitors - therapeutic use (5) 5
fluorouracil (5) 5
hematology, oncology and palliative medicine (5) 5
leucovorin - administration & dosage (5) 5
receptor, epidermal growth factor - metabolism (5) 5
antineoplastic agents - adverse effects (4) 4
breast cancer (4) 4
carcinoma (4) 4
care and treatment (4) 4
chemistry, medicinal (4) 4
colorectal-cancer (4) 4
doxorubicin (4) 4
enzyme inhibitors - pharmacology (4) 4
folinic acid (4) 4
head & neck cancer (4) 4
head and neck neoplasms - radiotherapy (4) 4
head and neck neoplasms - therapy (4) 4
locally advanced head (4) 4
medicine & public health (4) 4
nasopharyngeal carcinoma (4) 4
neoadjuvant therapy (4) 4
neoplasm recurrence, local - drug therapy (4) 4
neoplasm recurrence, local - pathology (4) 4
neoplasm staging (4) 4
neutropenia - chemically induced (4) 4
new drugs (4) 4
paclitaxel (4) 4
quality-of-life (4) 4
radiation therapy (4) 4
randomized trial (4) 4
randomized-trial (4) 4
receptor, epidermal growth factor - genetics (4) 4
squamous cell carcinoma of head and neck (4) 4
survival (4) 4
thiophenes - administration & dosage (4) 4
alkyl and aryl transferases - antagonists & inhibitors (3) 3
angiogenesis (3) 3
angiogenesis inhibitors - therapeutic use (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antibodies, monoclonal, humanized (3) 3
anticancer therapy (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
benzamides (3) 3
biochemistry & molecular biology (3) 3
biotechnology & applied microbiology (3) 3
breast neoplasms - drug therapy (3) 3
carcinoma - drug therapy (3) 3
carcinoma, squamous cell - pathology (3) 3
carcinoma, squamous cell - radiotherapy (3) 3
cell biology (3) 3
cell lung-cancer (3) 3
cells (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diagnostic Cytopathology, ISSN 8755-1039, 08/2015, Volume 43, Issue 8, pp. 654 - 658
Journal Article
Head & Neck, ISSN 1043-3074, 05/2015, Volume 37, Issue 5, pp. 763 - 770
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 583 - 594
Journal Article
Anti-Cancer Agents in Medicinal Chemistry, ISSN 1871-5206, 2013, Volume 13, Issue 9, pp. 1383 - 1390
Integration of geriatric assessment into cancer clinical practice is strongly needed in squamous cell carcinoma of the head and neck (SCCHN) due to the... 
Comprehensive geriatric assessment | Recurrent/metastatic squamous cell carcinoma of the head and neck | Activity daily living | Toxicity | Mini nutritional assessment | Early stage squamous cell carcinoma of the head and neck | Chronologic age | Radiotherapy | Elderly patients | Beers criteria | Charlson comorbidity index | Biologic age | Chemotherapy | Surgery | Vulnerable elders survey | Mini mental state examination | Instrumental activity daily living | Locally advanced squamous cell carcinoma of the head and neck | toxicity | elderly patients | early stage squamous cell carcinoma of the head and neck | biologic age | mini nutritional assessment | chemotherapy | instrumental activity daily living | QUALITY-OF-LIFE | PERFORMANCE STATUS | CHEMISTRY, MEDICINAL | PLUS CETUXIMAB | comprehensive geriatric assessment | RANDOMIZED-TRIAL | locally advanced squamous cell carcinoma of the head and neck | RADIATION-THERAPY | beers criteria | recurrent/metastatic squamous cell carcinoma of the head and neck | charlson comorbidity index | OLDER PATIENTS | ONCOLOGY | radiotherapy | SQUAMOUS-CELL CARCINOMA | chronologic age | vulnerable elders survey | LOCALLY ADVANCED HEAD | mini mental state examination | surgery | COOPERATIVE-ONCOLOGY-GROUP | Aged, 80 and over | Head and Neck Neoplasms - diagnosis | Aged | Humans | Head and Neck Neoplasms - therapy
Journal Article
BMC Cancer, ISSN 1471-2407, 11/2016, Volume 16, Issue 1, p. 918
Journal Article
Oncology, ISSN 0030-2414, 03/2013, Volume 84, Issue 4, pp. 251 - 254
Journal Article
Reviews on Recent Clinical Trials, ISSN 1574-8871, 09/2011, Volume 6, Issue 3, pp. 259 - 265
Journal Article
Oncology, ISSN 0030-2414, 08/2015, Volume 89, Issue 3, pp. 125 - 136
Tobacco use and alcohol consumption are the main risk factors associated with head and neck squamous cell carcinoma (SCC) development due to their cytotoxic... 
Review | Head and neck cancer | Human papillomavirus | Epstein-Barr virus | Tumorigenesis | VACCINE | HUMAN-PAPILLOMAVIRUS | HPV-DNA | TOBACCO | NASOPHARYNGEAL CARCINOMA | ALCOHOL | ONCOLOGY | POOLED ANALYSIS | CIGARETTE-SMOKE | SQUAMOUS-CELL CARCINOMAS | INTERNATIONAL HEAD | Smoking - adverse effects | Receptor, Epidermal Growth Factor - genetics | TOR Serine-Threonine Kinases - metabolism | Cancer Vaccines - pharmacology | Humans | Receptor, Epidermal Growth Factor - drug effects | MicroRNAs - metabolism | Human papillomavirus 16 - drug effects | Phosphatidylinositol 3-Kinases - metabolism | Receptor, Epidermal Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Head and Neck Neoplasms - epidemiology | Phosphatidylinositol 3-Kinases - drug effects | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Cetuximab | Oncogene Protein v-akt - metabolism | TOR Serine-Threonine Kinases - drug effects | Molecular Targeted Therapy - methods | Papillomavirus Infections - complications | Carcinoma, Squamous Cell - epidemiology | Oncogene Protein v-akt - drug effects | Risk Factors | Head and Neck Neoplasms - drug therapy | Alcohol Drinking - adverse effects | Carcinoma, Squamous Cell - etiology | Carcinoma, Squamous Cell - drug therapy | Mutation - drug effects | Signal Transduction - drug effects | Head and Neck Neoplasms - etiology | Epstein-Barr Virus Infections - complications | DNA Methylation - drug effects | Head & neck cancer | Molecular biology | Drug therapy | Epidemiology
Journal Article
Nature, ISSN 0028-0836, 12/2015, Volume 528, Issue 7580, pp. 84 - 87
Large cancer cell line collections broadly capture the genomic diversity of human cancers and provide valuable insight into anti-cancer drug response. Here we... 
DRUG-SENSITIVITY | MULTIDISCIPLINARY SCIENCES | Pharmacogenetics | Reproducibility of Results | Datasets as Topic | Neoplasms - genetics | Humans | Inhibitory Concentration 50 | Cell Line, Tumor - drug effects | Neoplasms - pathology | Databases, Factual | Neoplasms - drug therapy | Drugs | Studies | Datasets | Correlation analysis | Genomics | Pharmacology | Cancer
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 03/2019, Volume 30, Issue 3, pp. 308 - 312
Undifferentiated sinonasal carcinoma (SNUC) is defined as a small round blue cell tumor that is immunohistochemically distinct from other sinonasal... 
Tri-modality treatment | Chemotherapy | Sinonasal carcinoma | Radiotherapy | Paranasal | SURVIVAL | paranasal | tri-modality treatment | PATTERNS | chemotherapy | CANCER | SNUC | THERAPY | ONCOLOGY | radiotherapy | PHARMACOLOGY & PHARMACY | OUTCOMES | sinonasal carcinoma
Journal Article